Mrs. Anjum P. Hussain, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 255 Ne 19th Dr, Okeechobee, FL 34972 Phone: 863-467-8398 Fax: 863-467-9850 |
Sima Seidman Kurland, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Us Highway 441 N, Okeechobee, FL 34972 Phone: 863-763-1951 Fax: 863-357-2991 |
Debra S Mulrooney, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Us Highway 441 N, Okeechobee, FL 34972 Phone: 863-763-1951 Fax: 863-357-2991 |
Pamela Y Rogers, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Us Highway 441 N, Okeechobee, FL 34972 Phone: 863-763-1951 Fax: 844-540-4798 |
Dr. Karen E. Coley-piccirillo, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Us Highway 441 N, Okeechobee, FL 34972 Phone: 863-763-1951 Fax: 844-540-4798 |
Irma E. Romero, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Us Highway 441 N, Okeechobee, FL 34972 Phone: 863-763-1951 Fax: 445-404-7988 |
Serena Vidanage, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Us Highway 441 N, Okeechobee, FL 34972 Phone: 863-763-1951 Fax: 863-357-2991 |
News Archive
Scientists of the Institute of Structural Biology of Helmholtz Zentrum München and the Technische Universität München have succeeded in elucidating the structure of an important region of the Sam68 protein. Sam68 is a key protein for cellular signal transduction. The Journal of Biological Chemistry has selected the report of these research findings as one of two "papers of the week" for its September 10, 2010 issue and has chosen the structural model as cover image.
First-of-its-kind study finds that black cancer survivors on these plans are far more likely to struggle to afford health care and medicine than their white counterparts, while black and white cancer survivors on other types of plans are equally unlikely to face these challenges.
Mayo Clinic scientists have shown that injections of a hunger hormone blocker in mice can halt the typical weight gain after dieting and help prevent rebound obesity in the long term. The research findings appear in the Proceedings of the National Academy of Sciences.
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Synerx Pharma, LLC announced today the FDA approval and launch of Isosulfan Blue Injection 1%.
Researchers from the School of Basic & Medical Biosciences have identified a potential target that could lead to new treatments for triple negative breast cancer.
› Verified 6 days ago